Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial

Author(s):
Derks, M.G.M.; Blok, E.J.; Seynaeve, C.; Nortier, J.W.R.; Kranenbarg, E.M.K.; Liefers, G.J.; Putter, H.; Kroep, J.R.; Rea, D.; Hasenburg, A.; Markopoulos, C.; Paridaens, R.; Smeets, J.B.E.; Dirix, L.Y.; Velde, C.J.H. van de (0000-0003-0104-1800)
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-09-30
Language
English
Is part of
The Lancet Oncology (2017), Vol. 18, no. 9, p. 1211-1220
hdl
1887/114938
doi
10.1016/S1470-2045(17)30419-9